DC-Y13-27

DC-Y13-27, a derivative of DC-Y13, is a YTHDF2 inhibitor (KD: 37.9 μM). DC-Y13-27 enhances tumor responses to radiotherapy and immunotherapy.

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	550	In-stock
500mg	850	In-stock
1g	1300	In-stock
2g	get quote	In-stock
5g	get quote	In-stock
10g	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670


Purity	>98%
Formula	C14H10N2O2S
Mol Weight	270.306
Color	yellow to orange
State	solid
Solubility	Soluble in DMSO
Shelf Life	>3 years if stored properly
Storage	Powder 4℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Wang L, et al. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell. 2023 May 15:S1535-6108(23)00163-0.
CoA	CoA of DC-Y13-27

Smiles:	N#C/C(C(N)=O)=C\C1=CC=C(C2=CC(O)=CC=C2)S1


		Search